Logo Logo
Hilfe
Hilfe
Switch Language to English

Müller, Anna-Lena; Brockmüller, Aranka; Fahimi, Niusha; Ghotbi, Tahere; Hashemi, Sara; Sadri, Sadaf; Khorshidi, Negar; Kunnumakkara, Ajaikumar B. und Shakibaei, Mehdi (2022): Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment. In: Biomedicines, Bd. 10, Nr. 4, 832

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Colorectal cancer (CRC) is one of the most common tumors worldwide, with a higher rate of distant metastases than other malignancies and with regular occurrence of drug resistance. Therefore, scientists are forced to further develop novel and innovative therapeutic treatment strategies, whereby it has been discovered microorganisms, albeit linked to CRC pathogenesis, are able to act as highly selective CRC treatment agents. Consequently, researchers are increasingly focusing on bacteriotherapy as a novel therapeutic strategy with less or no side effects compared to standard cancer treatment methods. With multiple successful trials making use of various bacteria-associated mechanisms, bacteriotherapy in cancer treatment is on its way to become a promising tool in CRC targeting therapy. In this study, we describe the anti-cancer effects of bacterial therapy focusing on the treatment of CRC as well as diverse modulatory mechanisms and techniques that bacteriotherapy offers such as bacterial-related biotherapeutics including peptides, toxins, bacteriocins or the use of bacterial carriers and underlying molecular processes to target colorectal tumors.

Dokument bearbeiten Dokument bearbeiten